ARTG 431570BioGlue Surgical Adhesive - Surgical adhesive/sealant, animal-derived
ARTG ID: 431570 · Cryolife Medical (Australia) Company Pty Ltd · Artivion Inc · Class III · Started December 21, 2023
Good Name: Cryolife Medical (Australia) Company Pty Ltd - BioGlue Surgical Adhesive - Surgical adhesive/sealant, animal-derived
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 431570
- Start Date
- December 21, 2023
- Effective Date
- December 21, 2023
- Name
- Artivion Inc
- Country
- United States of America
- Address
- 1655 Roberts Boulevard NW, Kennesaw, Georgia, 30144
BioGlue Surgical Adhesive is indicated for use as an adjunct to standard methods of surgical repair (such as sutures, staples, and/or patches) to adhere, seal, and/or reinforce soft tissue. Indicated soft tissues are cardiac, vascular, pulmonary, and dural.
Access comprehensive regulatory information for BioGlue Surgical Adhesive - Surgical adhesive/sealant, animal-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 431570 and sponsored by Cryolife Medical (Australia) Company Pty Ltd, manufactured by Artivion Inc in United States of America. The device registration started on December 21, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.